GMO TECH Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

GMO TECH has a total shareholder equity of ¥970.0M and total debt of ¥245.0M, which brings its debt-to-equity ratio to 25.3%. Its total assets and total liabilities are ¥2.5B and ¥1.6B respectively. GMO TECH's EBIT is ¥780.0M making its interest coverage ratio 390. It has cash and short-term investments of ¥1.1B.

Anahtar bilgiler

25.3%

Borç/özkaynak oranı

JP¥245.00m

Borç

Faiz karşılama oranı390x
NakitJP¥1.15b
EşitlikJP¥970.00m
Toplam yükümlülüklerJP¥1.57b
Toplam varlıklarJP¥2.54b

Son finansal sağlık güncellemeleri

Recent updates

Here's Why We Think GMO TECH (TSE:6026) Is Well Worth Watching

Sep 13
Here's Why We Think GMO TECH (TSE:6026) Is Well Worth Watching

GMO TECH, Inc. (TSE:6026) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Aug 10
GMO TECH, Inc. (TSE:6026) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Is GMO TECH (TSE:6026) A Risky Investment?

Aug 02
Is GMO TECH (TSE:6026) A Risky Investment?

GMO TECH, Inc. (TSE:6026) Soars 33% But It's A Story Of Risk Vs Reward

Feb 27
GMO TECH, Inc. (TSE:6026) Soars 33% But It's A Story Of Risk Vs Reward

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 6026's short term assets (¥2.3B) exceed its short term liabilities (¥1.4B).

Uzun Vadeli Yükümlülükler: 6026's short term assets (¥2.3B) exceed its long term liabilities (¥188.0M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 6026 has more cash than its total debt.

Borcun Azaltılması: Insufficient data to determine if 6026's debt to equity ratio has reduced over the past 5 years.

Borç Kapsamı: 6026's debt is well covered by operating cash flow (131.4%).

Faiz Kapsamı: 6026's interest payments on its debt are well covered by EBIT (390x coverage).


Bilanço


Sağlıklı şirketleri keşfedin